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Purpose: Hydrogen is a proven novel antioxidant that selectively reduces hydroxyl
radicals. In this study, we investigated the effects of hydrogen-rich saline solution on
the prevention of renal injury induced by ischemia/reperfusion (I/R) and on renal function
recovery.
Methods: A rat model of renal I/R injury was induced by 45 min occlusion of the left
renal pedicle, followed by 108 h reperfusion. The right kidney was surgically removed.
Then, 0.9% NaCl solution (1 ml/kg) or hydrogen-rich saline solution (HRSS; 1 ml/kg) was
injected into the abdominal cavity at 4 h intervals. We assessed the influence of HRSS
or control saline solution on the recovery of renal function after I/R injury. Kidney tissues
were taken at different time points (24, 36, 48, 72, and 108 h after reperfusion) and
frozen (−80◦C). Kidney cell apoptosis was evaluated using terminal deoxynucleotidyl
transferase dUTP nick end labeling (TUNEL)-positive staining. Additionally, the apoptotic
factors (Bcl-2, Bax, caspase-3, caspase-9, and caspase-8) and the pro-inflammatory
cytokines (IL-6 and TNF-α) were measured in the kidney tissues. Finally, serum blood
urea nitrogen (BUN) and creatinine (Cr) levels were measured.
Results: Histological analyses revealed a marked reduction of interstitial congestion,
edema and hemorrhage in renal tissue after HRSS treatment compared to saline
treatment. After I/R injury, BUN, Cr, Bcl-2, caspase-3, caspase-9, caspase-8, IL-
6, and TNF-α were all significantly increased, while Bax expression was decreased.
HRSS remarkably reversed these changes. Moreover, BUN and Cr decreased more
rapidly in the rats treated with HRSS compared to the rats treated with control saline
solution.
Conclusions: HRSS showed a protective effect in the prevention of renal injury and
could promote renal function recovery after I/R injury in rats. HRSS might partially exert
its role through an anti-apoptotic and anti-inflammatory action in kidney cells.
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INTRODUCTION
Renal ischemia-reperfusion (I/R), an important cause of acute
kidney injury, is unavoidable during various types of operations,
such as renal transplantation, surgical revascularization of the
renal artery, partial nephrectomy and treatment of suprarenal
aortic aneurysms (Perico et al., 2004; Sharples et al., 2005;
Habib et al., 2015; Stangenberg et al., 2015). The mechanisms
responsible for the pathogenesis of renal damage remain largely
unknown, although reactive oxygen species (ROS) and apoptosis
seem to be involved (Sun et al., 2016). Experimental and
clinical studies have demonstrated the pivotal role of oxidative
stress that is associated with ROS overproduction. Oxidative
stress produces a large number of inflammatory factors, may
cause lipid peroxidation compromising the integrity of cellular
membranes, and promoting renal injury and cell apoptosis. In
addition, ROS, including the superoxide anion (O2−), hydrogen
peroxide (H2O2) and hydroxyl radicals (rOH), are believed
to play an important role in secondary injury (Fukui et al.,
2002; Sheu et al., 2006; Melcher and Moerschbacher, 2016).
At high concentrations, ROS cause cytotoxicity by damaging
proteins and nucleic acids, which leads to kidney cell apoptosis.
Consequently, anti-apoptotic and anti-inflammatory treatments
are being developed for kidney injury treatment.
Recently, it was demonstrated that molecular hydrogen (H2)
could selectively reduce cytotoxic ROS and reactive nitrogen
species, such as rOH and ONOO− in vitro, and could exert
therapeutic antioxidant and anti-inflammatory activity in many
animal models (Fukuda et al., 2007; Ohsawa et al., 2007). H2
is present in almost every chemical compound and everywhere
in nature. Its mild reductive reactivity minimizes its disturbance
on metabolic oxidation-reduction and ROS-related cell signaling,
avoiding serious side effects in medical procedures (Hayashida
et al., 2008). In addition, H2 is advantageous over many other
antioxidants because it can penetrate biomembranes as a gas.
Its diffusion to cellular organelles helps to effectively target
intracellular inflammatory factors. Previous studies showed that
the inhalation of H2 exerts protective effects on brain, liver, heart,
and intestinal I/R injuries (Bali et al., 2015; Malik and Ferguson,
2015; Du et al., 2016; Nagpure and Bian, 2016). Moreover, H2
acts as an anti-inflammatory agent in acute pancreatitis, colon
inflammation and liver inflammation (Cheng et al., 2014; Yemm
et al., 2015; Han et al., 2016).
However, H2 gas inhalation as a clinical application is
not convenient and may be dangerous because of its high
flammability. Compared with hydrogen gas, H2 saturated saline
solution (i.e., a hydrogen-rich saline solution, HRSS) is safe and
easy to administer. HRSS has also been implicated in attenuating
I/R-induced renal injury (Shingu et al., 2010; Wang et al., 2011,
2014). Some studies have also shown that H2 can protect the
kidneys from drug injuries (Matsushita et al., 2011; Katakura
et al., 2012). It remains unknown, however, whether HRSS
can facilitate renal function recovery after I/R injury in rats.
Therefore, the present study aims to investigate HRSS therapeutic
effects on renal I/R injury after 108 h reperfusion. In addition, we





Hydrogen-rich saline solution was prepared as previously
described (Cai et al., 2009). Briefly, hydrogen was dissolved in
saline solution for 6 h under high pressure (0.4 MPa) using
an apparatus manufactured in our department. The saturated
hydrogen saline solution was stored under atmospheric pressure
at 4◦C in an aluminum bag with no dead volume. HRSS was
sterilized by gamma radiation. To ensure that a concentration of
0.6 mmol/L was maintained, HRSS was freshly prepared every
week. The hydrogen content of HRSS was confirmed using the
gas chromatography method described by Ohsawa et al. (2007).
Animals
Sprague Dawley (SD) rats (250–300 g) were kept in standard
cages under a 12-h light/dark cycle. All experimental procedures
were approved by the Institutional Animal Care and Use
Committee of Jinling Hospital (Nanjing, China).
Experimental Protocols
Animals were divided into four groups: (1) sham-operated rats
receiving vehicle physiological saline solution treatment (control
group, n = 30); (2) I/R rats receiving vehicle physiological saline
solution treatment (I/R group, n = 30); (3) I/R rats receiving
HRSS treatment at 4 h intervals for a total of 108 h (long-term
treatment group, n = 30); (4) I/R rats receiving HRSS treatment
for 24 h and then vehicle physiological saline solution treatment
for 84 h (short-term treatment group, n = 30). In the control
group, rats received a sham operation, followed by a continuous
intraperitoneal administration of 0.9% NaCl solution (1 ml/kg).
In the I/R group, the right kidney was surgically removed, and
the left renal artery was occluded. This operation was followed by
intraperitoneal administration of 0.9% NaCl solution (1 ml/kg)
at 4 h intervals. Left renal artery occlusion was performed for
45 min under pentobarbital anesthesia. In the HRSS-I/R groups,
the right kidney was surgically removed, and the left renal artery
was occluded (Shingu et al., 2010; Wang et al., 2011). This was
followed by intraperitoneal administration of HRSS (1 ml/kg)
immediately after reperfusion at 4 h intervals. Occlusion of the
left renal artery was performed as described above. Rats received
saline solution or HRSS immediately after reperfusion at 4 h
intervals for a total of 108 h. The animals were anesthetized by
intraperitoneal injection of pentobarbital (Biomics Laibo, Beijing;
0.7 mg/kg) before any surgical treatments.
Analysis of Renal Function
Blood urea nitrogen and Cr were measured to evaluate renal
function. Samples were analyzed using commercial kits (Sigma,
St. Louis, MO, USA) and a COBAS Mira chemical analyzer
(Roche, Basel, Switzerland).
Histological Analyses
Renal samples were embedded in paraffin, cut into 4 µm
sections and stained with hematoxylin and eosin (H&E). Samples
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evaluation was performed under light microscopy by experienced
technicians blinded to the groups. These expert observers made
all assessments. To assess tubular injury, the percentages of
tubules in the outer medulla and corticomedullary junction with
tubular cell necrosis, cytoplasmic vacuole formation, hemorrhage
and tubular dilatation were measured. Semi-quantitative injury
scores ranged from 0 to 5 (0: normal kidney; 1: 0–10% injury; 2:
11–25% injury; 3: 26–45% injury; 4: 46–75% injury; 5: 76–100%
injury).
In Situ Apoptosis Assay
Kidneys were perfused with PBS (50 ml) using the transcardiac
approach, followed by 4% phosphate-buffered formalin.
Perfusion-fixed kidney tissues were further fixed overnight in a
solution of 4% paraformaldehyde in PBS, embedded in paraffin
and cut into 4 µm serial sections. Terminal deoxynucleotidyl
transferase dUTP nick end labeling (TUNEL) staining was
performed on paraffin embedded sections by using an in situ cell
death detection kit (Roche, Indianapolis, USA). According to
standard protocols, the sections were dewaxed and rehydrated
by heating the slides at 60◦C. Then, these sections were
incubated in a proteinase K working solution (20 mg/ml) for
15 min at room temperature. The slides were rinsed three
times with PBS before the incubation in the TUNEL reaction
mixture for 1 h at 37◦C. The area around the sample was
dried by filter paper, and Converter-AP was added to the
samples for 1 h at 37◦C. After rinsing with PBS (5 min, three
times), sections were stained with nitroblue tetrazolium (NBT)
and 5-bromo-4-chloro-3-indolylphosphate (BCIP) until they
became dark. Four slide fields were randomly examined using
a defined rectangular field area at 100× magnification. One
hundred cells were counted in each field. Data are shown as
percentage of TUNEL-positive cells of the total cell nuclei per
field.
FIGURE 1 | Alterations in renal morphology and function before and after renal I/R injury with and without hydrogen-rich saline solution (HRSS)
treatment. (A) Kidneys gross structure. (B) Histological examination by H&E staining (×100). (C) Renal function at 24 h after I/R injury with and without HRSS
treatment. (D) Creatine (Cr) and (C) blood urea nitrogen (BUN) were significantly reduced in HRSS-treated kidneys (P < 0.01).
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FIGURE 2 | Long-term HRSS treatment attenuated renal I/R injury.
Short-term HRSS treatment (STT) after renal I/R injury reduced renal injury, but
renal function deteriorated once the treatment was stopped. In contrast,
long-term HRSS treatment (LTT) markedly reduced renal injury and
accelerated renal function recovery. (A) Blood creatinine. (B) Blood urea
nitrogen.
Immunohistochemistry
Bax and Bcl-2 imunohistochemical evaluation was carried out
as previously described (Nakamura et al., 2007). Five µm tissue
sections were deparaffinized, rehydrated in gradient alcohols and
processed using the streptavidin immunoperoxidase method. In
brief, sections were submitted to antigen retrieval by microwave
oven treatment for 10 min in 0.01 mol/L citrate buffer (pH
6.0). Slides were then incubated in 10% normal serum for
30 min, followed by an overnight incubation at 4◦C with the
appropriately diluted primary antibody. Bax and Bcl-2 antibodies
(Beyotime Inc., China) were used at 1:100 dilution. Next,
samples were incubated with biotinylated anti-mice or anti-rabbit
immunoglobulins for 15 min at 37◦C. Then, they were incubated
with streptavidin peroxidase complexes for 15 min at 37◦C. Four
slide fields were randomly examined using a defined rectangular
field area at 400×magnification. Bax and Bcl-2 positive cells were
counted in each field. Data are shown as the number of Bax and
Bcl-2 positive cells per field.
Cytokine Measurement in Kidney Tissues
Kidney tissues were collected and washed with normal saline
solution. Then, they were immediately homogenized in 1 ml of
cold normal saline solution (4◦C) on ice. The homogenates were
centrifuged at 3,000× g at 4◦C for 15 min. Caspase-3, caspase-9,
and caspase-8 activities were evaluated using a Fluorometric
Assay Kit (BIOVISION Research Products, Mountain View, CA,
USA), according to the manufacturer’s instructions. IL-6 and
TNF-α were measured with a commercial ELISA kit, according
to the manufacturer’s instructions (Dakawe, Shenzhen, China).
Statistical Analyses
Data are expressed as mean ± standard deviation (SD). Each
experiment was repeated three times, and data represent the
means from at least three parallel samples. SPSS version
11.0 (SPSS Inc., Chicago, USA) was used for all statistical
analyses. Analysis of variance (ANOVA) and Student’s t-test
were used to determine the differences among and between
groups, respectively. P-values of less than 0.05 were considered
statistically significant.
RESULTS
Hydrogen Exerted a Protective Effect on
I/R-Induced Renal Injury
In a preliminary study of hydrogen’s protective effect in kidneys,
we analyzed kidney morphology and function at 24 h after
I/R injury, and we found similar results to previous studies
(Shingu et al., 2010; Wang et al., 2011, 2014). As shown in
Figure 1, HRSS significantly reduced renal I/R injury. After
HRSS treatment, renal tubule denaturation and edema were
significantly attenuated (Figure 1A). Histology results in the
normal kidney show that the renal glomerulus and tubules
structures were clear without hemorrhage in the renal tubule,
without loss of epithelial cells. In contrast, renal tubules in the I/R
injured kidney showed evident edema, an almost complete loss
of the epithelium and infiltration of red blood cells. The HRSS-
treated kidney showed a partial loss of the epithelium in the
renal tubules, and the number of red blood cells was significantly
decreased, compared to the I/R injured kidney (Figure 1B).
Additionally, serum Cr and BUN levels of the rats in the HRSS
treatment group were significantly reduced when compared to
the control group (P < 0.01; Figure 1C).
Additionally, we detected renal cell apoptosis by TUNEL
immunostaining. As shown in Figures 4A,B, TUNEL-positive
renal cells were significantly reduced at 24 h after I/R injury in
the short-term and long-term treatment groups when compared
to the I/R group. However, in the short-term treatment group,
renal cell apoptosis still occurred after discontinuation of HRSS
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treatment, while it remained significantly reduced in the long-
term treatment group.
In order to further verify HRSS therapeutic effect on renal I/R
injury, we analyzed kidney morphology by H&E staining after
I/R injury. At 24 h after I/R injury, renal tubular necrosis was
significantly reduced in the short-term and long-term treatment
groups. Renal hemorrhage and edema were also significantly
attenuated, compared to the I/R group. Continuous HRSS
treatment accelerated the recovery of the renal tubules function,
when compared with short-term treatment. Histology scores for
renal injury showed similar results (Figure 3).
Hydrogen Could Promote the Recovery
of Renal Function
Previous studies on hydrogen and I/R injury mainly focus on
the ability of hydrogen on inhibiting ROS to reduce renal
I/R injury. It has been well established, however, that the
oxidation reaction after I/R injury is a lengthy process and
can cause sustained renal injury. Therefore, we speculated
that continuous HRSS treatment could promote renal function
recovery. To test this hypothesis, we monitored renal function
at different time points after I/R injury. When compared with
the I/R group, the long-term and short-term treatment groups
showed significantly reduced renal function impairment, and
the renal function was rapidly recovered. However, compared
with the short-term treatment group, renal function recovery
in the long-term treatment group was faster. In addition, we
also unexpectedly found that serum Cr and BUN increased
in the short-term treatment group after discontinuation of
HRSS treatment (Figure 2). These results indicated that
after renal I/R injury, continuous HRSS treatment exerted
a significantly enhanced therapeutic effect and promoted
more rapid renal function recovery than short-term HRSS
treatment.
Effect of HRSS on Pro-inflammatory
Cytokines and Apoptotic Factors’ Levels
In order to determine the effect of HRSS treatment on
inflammatory cytokine levels in kidney tissue, we measured
TNF-α and IL-6 expression by ELISA. As shown in Figures 4C,D,
inflammatory cytokines levels in the short-term and long-
term treatment groups were significantly reduced at 24 h after
I/R injury, when compared to the I/R group. However, after
discontinuation of HRSS treatment, the inflammatory cytokine
FIGURE 3 | Long-term HRSS treatment prevented delayed injury after renal I/R injury. In the STT group, delayed renal injury, such as renal edema, epithelial
cell loss and increased red blood cells in the renal tubule, occurred once the treatment stopped and were suppressed by long-term HRSS treatment. Histological
changes observed after renal I/R injury included tubular cell necrosis, cytoplasmic vacuole formation, hemorrhage and tubular dilatation. Injury scores are expressed
as mean ± SD. Semi-quantitative injury scores ranged from 0 to 5 (0: normal kidney; 1: 0–10% injury; 2: 11–25% injury; 3: 26–45% injury; 4: 46–75% injury; 5:
76–100% injury).
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FIGURE 4 | Hydrogen inhibited renal cell apoptosis after renal I/R injury. Apoptosis in I/R kidneys receiving long-term or short-term HRSS-treatment (A,B;
×100), TNF-α (C) and IL-6 (D) expression in the STT and LTT groups were reduced (P < 0.05). (E) Caspase-9, caspase-8, and caspase-3 expressions were
markedly decreased in the kidneys of rats in the LTT group (P < 0.01).
levels in the kidney tissues of the short-term treatment group
were increased, while in the long-term treatment group these
levels continuously decreased.
To further study the mechanism by which HRSS reduces
renal cell apoptosis, Bcl-2 and Bax renal expressions were
analyzed at 24 h after I/R injury by immunohistochemistry
(Figure 5A). Bcl-2 expression in the HRSS treatment group
was increased compared to the I/R group, while Bax expression
was slightly decreased. However, these differences between
the two groups were not statistically significant (P > 0.05;
Figures 5B,C). We also compared the Bcl-2/Bax ratios in the I/R
and hydrogen treatment groups, and we found that this ratio was
significantly increased in the HRSS treatment group (P < 0.05;
Figure 5D).
Because activation of caspase-3, caspase-8, and caspase-9 plays
an important role in apoptosis induction, we analyzed their
expression in kidney tissue. As shown in Figure 4E, caspase-3,
caspase-8, and caspase-9 levels in the short-term and long-term
treatment groups were significantly reduced compared to the I/R
group (P < 0.01; Figure 4E).
DISCUSSION
This study showed HRSS ability to promote renal function
recovery after I/R injury in rats by inhibiting the inflammatory
TNF-α /IL-6 pathway, increasing the Bcl-2/Bax ratio and
attenuating kidney cell apoptosis. Our results indicated that
continuous HRSS treatment was beneficial in preventing and
treating renal I/R injury.
Hydrogen, a safe and effective antioxidant with minimal side
effects, can effectively neutralize hydroxyl radicals. Several studies
have demonstrated the protective effects of H2 by using HRSS
to increase cellular antioxidative defense mechanisms. Ohsawa
et al. (2007) first reported that hydrogen gas had a protective
effect against cerebral I/R injury. In addition, other studies have
reported that hydrogen gas can protect against organ dysfunction
induced by various I/R injuries (Chen et al., 2011; Lee et al., 2015).
Renal I/R injury is common in several clinical situations,
including renal transplantation and shock. I/R-induced acute
renal failure is associated with decreased allograft survival in
kidney transplant patients and with high mortality and morbidity
in patients with native kidneys. Many studies have shown that
hydrogen can inhibit the expression of inflammatory cytokines,
thereby reducing renal I/R injury (Koning et al., 2015; Shi
et al., 2015). However, in these studies expression of various
inflammatory cytokines and apoptosis-related proteins in the
kidney tissues was only measured at 24 h after I/R injury
(Shingu et al., 2010; Wang et al., 2011). No detailed study on
the subsequent recovery of renal function has been reported.
Therefore, in this study, we compared the protective effects of
long-term and short-term HRSS treatment on renal function after
I/R injury and we analyzed the protective mechanisms.
Creatinine and BUN are the most commonly used markers
for renal function assessment. Previous studies have found that
serum Cr and BUN levels in rats treated with HRSS after renal
I/R injury were significantly decreased (Shingu et al., 2010;
Wang et al., 2011, 2014). However, I/R injury is a sustained
injury in the body. Previous studies only reported that hydrogen
had a protective effect on renal function at 24 h after I/R
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FIGURE 5 | (A) Hydrogen modulated Bcl-2 and Bax expression in renal tissue after I/R injury. (B) Bcl-2 expression was upregulated, while (C) Bax expression was
downregulated in renal tissue (P > 0.05). Although the change in Bax expression was not significant, (D) Bcl-2/Bax ratio was significantly altered (P < 0.05).
injury and did not study the subsequent renal recovery. Our
results demonstrate that 108 h of continuous HRSS treatment
promoted renal function recovery more rapidly than the short-
term 24 h HRSS treatment. In addition, serum Cr and BUN in
rats in the 24 h HRSS treatment group significantly increased
after discontinuation of the HRSS treatment, suggesting that
continuous HRSS treatment was beneficial for renal I/R injury
recovery.
Several studies have demonstrated that the increase of pro-
inflammatory cytokines such as IL-6 and TNF-α represents
one of the first renal inflammatory responses to hyperoxia,
which leads to renal tissue damage (Chen et al., 2015; Seo
and Jeong, 2015). These cytokines play important roles in
neutrophil activation and infiltration and induce both localized
tissue injury and remote organ injury. In the present study,
TNF-α and IL-6 concentrations in renal tissues were significantly
increased in I/R-induced renal injury. However, HRSS treatment
reversed the levels of inflammatory mediators while protecting
the renal tissue against I/R-induced oxidative injury. Thus,
hydrogen significantly reduced these proinflammatory cytokines
in kidney tissue, suggesting that its protective effect on kidney
injury might be mediated by the suppression of the intense
inflammatory response and its downstream cascade. Our study
has shown that continuous hydrogen administration could
inhibit IL-6 and TNF-α expression and thus protect renal
function.
Bcl-2 exerts anti-apoptotic effects through antioxidant activity
or inhibition of ROS generation. In contrast, Bax plays an
inductive role, promoting apoptosis through antagonizing Bcl-2.
A previous study by Korsmeyer et al. (1993) suggested that the
ratio of Bcl-2 to Bax determines whether apoptosis is induced or
inhibited. In the present study, we examined the anti-apoptotic
protein Bcl-2 and the pro-apoptotic protein Bax in kidney tissue.
Our results demonstrated that HRSS treatment can decrease Bcl-
2 and increase Bax protein expression. Our results suggested that
H2 protective mechanism was mediated by upregulation of the
Bcl-2:Bax ratio, thereby reducing kidney apoptosis induced I/R
injury.
The final pathway leading to apoptosis is the activation
of a series of proteases called caspases. Because the intrinsic
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(caspase-9) and extrinsic (caspase-8) apoptotic pathways
converge at the activation of caspase-3, we measured renal
caspase-3, caspase-8, and caspase-9 expressions (Juraver-Geslin
and Durand, 2015; Kim et al., 2015; Monie and Bryant, 2015).
Our results showed that HRSS reduced theirs expressions,
suggesting that hydrogen could inhibit apoptosis through
multiple pathways.
CONCLUSION
The results of this study demonstrated that HRSS treatment
attenuated renal I/R injury in a rat model. Taken together,
our results suggested that HRSS exerted anti-apoptotic and
anti-inflammatory effects to promote renal function recovery
after I/R injury in rats. Although the mechanisms involved
in hydrogen’s protective role remain to be fully elucidated,
peritoneal injection of hydrogen could represent an easy to use,
safe, cost efficient and effective novel approach for future kidney
injury protection.
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